International Journal of Biomedical Science and Engineering
Volume 2, Issue 4, August 2014, Pages: 33-37
Received: Sep. 16, 2014;
Accepted: Sep. 22, 2014;
Published: Sep. 30, 2014
Views 3241 Downloads 115
Nicholas Israel Nii-Trebi, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana
James Ashun Mensah Brandful, Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
William Kwabena Ampofo, Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
Billal Obeng Musah, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana
Jacob Samson Barnor, Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
Kenzo Tokunaga, Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan
Background: In Ghana, the HIV-1 profile has been quite dynamic. Previous reports identified HIV-1 subtypes A, D and G present and recently the CRF02_AG has been described as the predominant molecular form of HIV-1 in Kumasi, Ghana. This underscores the need for constant molecular characterization of HIV-1 species in the country. Objective: To provide current updates on the nature of HIV subtypes in Ghana, there is need for a user-friendly tool for routine monitoring of subtypes in the absence of cost-intensive and skill-demanding sequencing techniques. This work demonstrates the use of heteroduplex mobility assay (HMA) for rapid subtype detection of HIV-1 isolated from Ghanaian patients. Method: Viruses from 15 antibody-positive HIV-1 patients were isolated directly by co-culturing peripheral blood mononuclear cells (PBMC) with phytohemagglutinin (PHA)-stimulated donor PBMCs from an HIV seronegative individual and through HeLa cells positive for CD4/CXCR4/CCR5 (MAGIC-5A cells). That was followed by proviral DNA extraction. Heteroduplex Mobility Assay (HMA) technique was then performed on the HIV gag gene. Results: Using the HMA technique, newly isolated HIV-1 strains were subtyped as follows: There were seven subtype A (47%), two subtype G (13%) and six (40%) A/G recombinants. Conclusion: The HIV-1 CRF02_AG in Ghana has spread much more rapidly than the previously predominant subtype A over the years. Constant molecular characterization of HIV strains is necessary to enable clear elucidation of the prevailing HIV species in Ghana. This study presents the HMA as a useful tool for monitoring subtype emergence and distribution in the country.
Nicholas Israel Nii-Trebi,
James Ashun Mensah Brandful,
William Kwabena Ampofo,
Billal Obeng Musah,
Jacob Samson Barnor,
Rapid Detection of HIV-1 Subtypes in Ghana by Heteroduplex Mobility Assay, International Journal of Biomedical Science and Engineering.
Vol. 2, No. 4,
2014, pp. 33-37.
Jackson JB, Kwok SY, Sninsky JJ, Hopsicker JS, Sannerud KJ, Rhame FS, et al. Human Immunodeficiency Virus Type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol 1990; 28(1): 16-19.
Schechter MT, Craib KJ, Gelmon KA, Montaner JS, Le TN, O’Shughnessy MV. HIV-1 and the aetiology of AIDS. Lancet 1993; 341(13): 658-59.
UNAIDS Report on the Global AIDS Epidemic. http://www.unaids.org/globalreport/Global_report.htm, 2010
Coffin JM. Genetic diversity and evolution of retrovirus. Curr Top Microbiol Immunol 1992; 176: 143-64.
Wain-Hobson S. The fastest genome evolution ever described: HIV variation in situ. Curr Opin Genet Dev 1993; 3 (6): 878-83.
Malim MH, Emerman M. HIV-1 sequence variation: drift, shift, and attenuation. Cell 2001; 104 (4): 469-72.
Hu W-S, Temin HM. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudoploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990; 87 (4): 1556-60
Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455 (7213):661–4.
Wodarz D and Levy DN. Effect of different modes of viral spread on the dynamics of multiply infected cells in human immunodeﬁciency virus infection. J. R. Soc. Interface 2011, 8: 289-300 (doi:10.1098/rsif.2010.0266): Published online 21 July 2010, downloaded from rsif.royalsocietypublishing.org on February 19, 2014.
Peeters M and Sharp PM. Genetic diversity of HIV-1: The moving target. AIDS 2000; 14 (Suppl. 3): S129-40.
Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, et al. HIV-1 nomenclature proposal. Sci 2000; 288 (5463): 55-65.
Sharp PM, Bailes E, Chaudhuri RR, Rodenburg CM, Santiago MO, Hahn BH. The origins of acquired immune deficiency syndrome viruses: Where and when? Philos Trans R Soc Lond B Biol Sci 2001; 356 (1410): 867–76
Plantier J-C, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, et al.. A new human immunodeficiency virus derived from gorillas. Nat. Med 2009; 15:871– 872.
McCutchan, F. E. 2006. Global epidemiology of HIV. J. Med. Virol. 78(Suppl. 1):S7–S12.80.
McCutchan FE, Sankale J-L, M'Boup S, Kim B, Tovanabutra S, Hamel DJ et al. HIV Type 1 Circulating Recombinant Form CRF09_cpx from West Africa Combines Subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retrovir 2004; 20(8): 819-26.
Peeters, M. 2001. Recombinant HIV sequences: their role in the global epidemic, p. 54–72. In C. Kuiken, B. Foley, B. Hahn, F. E. McCutchan, J. W. Mellors, J. I. Mullins, J. Sodroski, S. Wolinsky, and B. Korber (ed.), HIV sequence compendium 2000. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
Lau KA, Wong JJ. Current trends of HIV recombination worldwide. Infect Dis Rep 2013; 5(Suppl 1): e4
Thomson MM, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lanc Infect Dis 2002; 2 (8): 461-71.
Hemelaar J., E. Gouws, P. D. Ghys, and S. Osmanov. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13–W23.
Carr JK, Avila M, Gomez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V, et al. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001; 15(15): F41-7.
McCutchan FE, Carr JK, Robb M, Birx D. Molecular epidemiology and global diversity of HIV-1. IAS Conf HIV Pathog Treat 2001; Ist: Abstract No. 142.
William E.Dowling, Bohye Kim, Carl J.Mason, K.Monique Wasunna, Uzma Alam, Lynne Elson, Deborah L.Birx, Merlin L.Robb, Francine, E.McCutchan and Jean K.Carr. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002, 16:1809–1820.
Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, et al. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virol 1998; 247 (July (1): 22-31.
Motomura, K., S. Kusagawa, K. Kato, K. Nohtomi, H. H. Lwin, K. M. Tun, M. Thwe, K. Y. Oo, S. Lwin, O. Kyaw, M. Zaw, Y. Nagai, and Y. Takebe. 2000. Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar. AIDS Res. Hum. Retrovir. 17:1831–1843.
McCutchan, F. E., J. K. Carr, M. Bajani, E. Sanders-Buell, T. O. Harry, T. C. Stoeckli, K. E. Robbins, W. Gashau, A. Nasidi, W. Janssens, and M. L. Kalish. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virol 1999; 254: 226–234.
Montavon C, Toure-Kane C, Liegeois F, Mpoudi E, Bourgeois A, Vergne L, et al. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Synd 2000; 23 (5): 363-74.
Fischetti L, Opare-Sem O, Candotti D, Sarkodie F, Lee H, Allain JP. Molecular epidemiology of HIV in Ghana: Dominance of CRF02_AG. J Med Virol 2004; 73 (2): 158-66.
Nii-Trebi NI, Ibe S, Barnor JS, Ishikawa K, Brandful JAM, et al. (2013) HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naı¨ve Patients after the Implementation of Antiretroviral Therapy in Ghana. PLoS ONE 8(8): e71972. doi:10.1371/journal.pone.0071972
Barouch DH. Challenges in the development of an HIV-1 vaccine. Nature 2008; 455 (2): 613-9.
Hahn BH, Robertson DL, McCutchan FE, Sharp PM. Recombination and diversity of HIV: implications for vaccine development. In: Girard M, Dodet B, editors. Retroviruses of Human AIDS and Related Diseases. Neuvieme Colloque des Cent Gardes 1994; 87-94.
Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, et al. Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates by gag/env Heteroduplex Mobility Assay. J Virol 2000; 74:(1): 363-70.
Andersson S, Norrgren H, Dias F, Biberfeld G, Albert J. Molecular characterization of human immunodeficiency virus (HIV-1) and –2 in individuals from Guinea-bissau wirh single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virol 1999; 262(2): 312-20.
Sawadogo S, Adje-Toure C, Bile CE, Ekpini RE, Chorba T, Nkengasong JN. Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Cote d’Ivoire. J Clin Microbiol 2003; 41 (7): 3056-9
Takehisa J, Osei-Kwasi M, Ayisi NK, Hishida O, Miura T, Igarashi T, et al. Phylogenetic analysis of human immunodeficiency virus 1 in Ghana. Acta Virol 1997; 41(1): 51-4.
McCutchan FE, Carr JK, Bajani M, Sanders-Buell E, Harry TO, Stoeckli TC, et al. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virol 1999; 254 (2): 226-34.